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Background
Transient gene expression (TGE) is a rapid method for
the production of recombinant proteins. Protein produc-
tivity in TGE has improved significantly over the past
decade, reaching 300 mg/L and 1 g/L in CHO DG44
(CHO) and HEK 293E (HEK) cells, respectively [1,2].
However, the amount of plasmid DNA needed for trans-
fection remains relatively high, contributing significantly
to the overall cost of the TGE process. In order to
reduce the amount of plasmid DNA in TGE, we exam-
ined the possibility of partially replacing it with herring
sperm DNA (non-coding “filler” DNA) in transfections
of CHO and HEK cells.
Materials and methods
Transfections
Suspension-adapted CHO were centrifuged and resus-
pended in ProCHO5 (Lonza, Verviers, Belgium) at a
density of 4 x 10
6 cells/mL. Transfections of 5 mL were
performed in TubeSpin
® 50 bioreactors (TPP, Trasadin-
gen, Switzerland) using 0.625 µg DNA/1x10
6 cells and
2.5 µg/1x10
6 cells of linear 25 kDa polyethyleneimine
(PEI; Polysciences, Eppenheim, Germany). pA3 carrying
the genes for a human IgG light and heavy chains was
used for transfections [1]. The transfected cultures were
incubated at 31 °C in 5% CO2 and 85% humidity with
agitation at 180 rpm. HEK cells were centrifuged and
resuspended at a density of 20 x 10
6 cells/mL in RPMI
1640 medium (Lonza). To each culture, 1.0 µg DNA/
1x10
6 cells and 3.0 µg PEI/1x10
6 cells were added. At 3
h post-transfection, cells were diluted with Ex-
Cell293
TM medium (Sigma) medium to a density of 1 x
10
6 cells/mL, and valproic acid was added to a final con-
centration of 3.75 mM. The transfected cultures were
incubated at 37 °C as above.
Analyses
The IgG concentration was determined by sandwich
ELISA [3]. To quantify plasmid DNA copy number,
total cellular DNA was extracted using DNeasy Blood &
Tissue Kit (Qiagen) according to the manufacturer’s
protocol. To estimate the mRNA transgene levels, total
RNA was extracted from cells using the GenElute
mRNA kit (Sigma) according to the manufacturer’sp r o -
tocol. DNA-free RNA was reverse transcribed using M-
MLV reverse transcriptase (Sigma) and oligo dT as the
primer. The RT-qPCR was carried out in a LightCycler
480 Real-Time PCR System (Roche Applied Science,
Basel, Switzerland) with the ABsolute QPCR SYBR
Green ROX mix (Thermo Fisher Scientific) according to
the manufacturer’s instructions.
Results
Filler DNA allows considerable reduction in coding pDNA
amounts
We tested the efficiency of herring sperm DNA as filler
for TGE in CHO and HEK cells. We reduced the
amount of pA3 to 17% or 33% of the optimum amount
for each cell line and added filler DNA to 100%. The
total amount of PEI was kept constant for all conditions.
We observed that antibody titers increased when filler
DNA was co-transfected with pA3 as compared to
transfection with a reduced amount of pA3 alone (Fig.
1 ) .T h e s er e s u l t ss h o w e dt h a tu pt o8 3%o ft h ec o d i n g
pDNA could be replaced by filler DNA with only a
minimal negative impact on yield. * Correspondence: florian.wurm@epfl.ch
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pDNA
We investigated whether the use of filler DNA could
improve pDNA delivery and/or intracellular pDNA sta-
bility by quantifying the plasmid copy number by qRT-
PCR. The results showed that the plasmid copy number
decreased proportionally with the amount of pA3 trans-
fected in the presence or absence of filler DNA in both
CHO and HEK cells (data not shown). Therefore, filler
DNA did not influence the delivery of coding pDNA to
transfected cells.
Filler DNA enhances transgene mRNA levels and
improves release of coding pDNA
We tested the hypothesis that the use of filler DNA
could influence transcriptional competence of coding
pDNA. By qPCR, we found that transgene mRNA levels
were significantly higher in the presence of filler than in
its absence (data not shown). This may explain the
improved protein titers observed in the presence of filler
DNA. We then hypothesized that filler DNA could
influence the strength of PEI:DNA complexes and
pDNA release from the complex upon delivery. With an
in vitro dextran sulfate displacement assay we observed
that with increasing PEI:DNA ratios, complex strength
increased. However, when filler DNA was added to the
complex, the release of pDNA from the complex was
improved (data not shown).
Conclusions
O u rd a t as h o wt h a ti nT G Et h ea m o u n to ft h ec o d i n g
vector could be reduced considerably by replacement of
a significant proportion of pDNA with filler DNA (her-
ring sperm DNA) without a major negative impact on
recombinant protein productivity. However, filler DNA
did not influence the delivery or stability of pDNA. The
addition of filler DNA to the DNA-PEI complex, how-
ever, relaxed the complex in vitro. Based on these
results, we speculate that the presence of filler DNA
results in a more efficient intracellular release of the
pDNA from the DNA-PEI complex and thus to
improved transgene transcription.
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Figure 1 Effect of filler DNA on transient IgG production in A) CHO and B) HEK cells. IgG titers were measured on day 7 post-transfection by
ELISA. The DNA amounts are presented in μg/10
6 cells.
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